PT2344892E - Acetaminofeno gucuronidado como um marcador de distúrbios hepáticos - Google Patents

Acetaminofeno gucuronidado como um marcador de distúrbios hepáticos Download PDF

Info

Publication number
PT2344892E
PT2344892E PT97407795T PT09740779T PT2344892E PT 2344892 E PT2344892 E PT 2344892E PT 97407795 T PT97407795 T PT 97407795T PT 09740779 T PT09740779 T PT 09740779T PT 2344892 E PT2344892 E PT 2344892E
Authority
PT
Portugal
Prior art keywords
gucuronidated
acetaminophen
marker
hepatic disorders
hepatic
Prior art date
Application number
PT97407795T
Other languages
English (en)
Inventor
Nathan Cherrington
Original Assignee
Univ Arizona State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Arizona State filed Critical Univ Arizona State
Publication of PT2344892E publication Critical patent/PT2344892E/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00Post-translational modifications [PTMs] in chemical analysis of biological material
    • G01N2440/38Post-translational modifications [PTMs] in chemical analysis of biological material addition of carbohydrates, e.g. glycosylation, glycation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/08Hepato-biliairy disorders other than hepatitis
    • G01N2800/085Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT97407795T 2008-10-01 2009-09-30 Acetaminofeno gucuronidado como um marcador de distúrbios hepáticos PT2344892E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19483508P 2008-10-01 2008-10-01

Publications (1)

Publication Number Publication Date
PT2344892E true PT2344892E (pt) 2014-08-25

Family

ID=41478549

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97407795T PT2344892E (pt) 2008-10-01 2009-09-30 Acetaminofeno gucuronidado como um marcador de distúrbios hepáticos

Country Status (21)

Country Link
US (2) US20110220500A1 (pt)
EP (1) EP2344892B8 (pt)
JP (2) JP2012504629A (pt)
KR (1) KR20110082148A (pt)
CN (1) CN102227641B (pt)
AU (1) AU2009298669B2 (pt)
BR (1) BRPI0920441A2 (pt)
CA (1) CA2738210A1 (pt)
CL (1) CL2011000654A1 (pt)
DK (1) DK2344892T3 (pt)
ES (1) ES2489016T3 (pt)
HK (1) HK1160223A1 (pt)
IL (1) IL211914A (pt)
MX (1) MX2011003497A (pt)
MY (1) MY156251A (pt)
NZ (1) NZ591981A (pt)
PL (1) PL2344892T3 (pt)
PT (1) PT2344892E (pt)
RU (1) RU2555331C2 (pt)
WO (1) WO2010039754A1 (pt)
ZA (1) ZA201102369B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200393473A1 (en) * 2018-02-26 2020-12-17 Arizona Board Of Regents On Behalf Of The University Of Arizona Ezetimibe metabolite as a non-invasive biomarker for non-alcoholic steatohepatitis (nash)
EP4390397A1 (en) * 2022-12-23 2024-06-26 Asociación Centro de Investigación Cooperativa en Biociencias - CIC bioGUNE Methods for diagnosing liver disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7090845B2 (en) * 1998-05-13 2006-08-15 Genentech, Inc. Diagnosis and treatment of hepatic disorders
FI20010019A (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
US7470513B2 (en) * 2003-11-10 2008-12-30 Academia Sinica Risk assessment for adverse drug reactions

Also Published As

Publication number Publication date
KR20110082148A (ko) 2011-07-18
JP2015155913A (ja) 2015-08-27
IL211914A0 (en) 2011-06-30
EP2344892B8 (en) 2014-11-12
ES2489016T3 (es) 2014-09-01
CA2738210A1 (en) 2010-04-08
PL2344892T3 (pl) 2014-10-31
ZA201102369B (en) 2012-09-26
AU2009298669B2 (en) 2016-04-07
CN102227641A (zh) 2011-10-26
AU2009298669A1 (en) 2010-04-08
RU2555331C2 (ru) 2015-07-10
CN102227641B (zh) 2015-04-22
MY156251A (en) 2016-01-29
NZ591981A (en) 2013-05-31
US20110220500A1 (en) 2011-09-15
BRPI0920441A2 (pt) 2017-05-30
IL211914A (en) 2015-09-24
MX2011003497A (es) 2011-07-29
EP2344892B1 (en) 2014-05-21
WO2010039754A1 (en) 2010-04-08
JP2012504629A (ja) 2012-02-23
CL2011000654A1 (es) 2011-08-19
RU2011117260A (ru) 2012-11-10
DK2344892T3 (da) 2014-08-18
EP2344892A1 (en) 2011-07-20
US20160209435A1 (en) 2016-07-21
HK1160223A1 (en) 2012-08-10

Similar Documents

Publication Publication Date Title
IL209382A0 (en) Water-soluble acetaminophen analogs
TWI561257B (en) Extended release oral acetaminophen/tramadol dosage form
ZA201002000B (en) Production of isoprenoids
EP2279410A4 (en) METHODS OF IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS
GB0724412D0 (en) Marker
GB0806281D0 (en) Markers of Oocyte viability
GB0900404D0 (en) New compounds 4
ZA201200888B (en) New tumor marker
GB0714573D0 (en) Marker gene
AU320441S (en) Marker
GB0822155D0 (en) Marker
GB0908071D0 (en) Marker
GB0905964D0 (en) Marker
PT2344892E (pt) Acetaminofeno gucuronidado como um marcador de distúrbios hepáticos
HK1159501A1 (en) Pharmaceutical composition comprising a prostaglandin
EP2478359A4 (en) METHOD FOR IDENTIFYING ANTI-INFLAMMATORY COMPOUNDS
GB0800637D0 (en) Evidence marker
GB0717319D0 (en) Photoluminescent marker
GB0701817D0 (en) Marker
AU2009901195A0 (en) Nogging marker
GB0804417D0 (en) Markers
GB0807654D0 (en) Meringue marker
GB0913387D0 (en) Acoustic marker
GB0705713D0 (en) Production of amines
GB0702309D0 (en) Hydro marker